VIVOZON PHARMACEUTICAL CO., LTD.
Develops multi-target drugs for pain and central nervous system (CNS) diseases.
082800 | KO
Overview
Corporate Details
- ISIN(s):
- KR7082800004
- LEI:
- Country:
- South Korea
- Address:
- 경기도 화성시 향남읍 제약공단2길 34-40, 화성시
- Website:
- https://www.vivozon.com/
- Sector:
- Manufacturing
Description
VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-28 00:00 |
사업보고서 (2022.12)
|
Korean | 2.0 MB | ||
| 2023-03-24 00:00 |
불성실공시법인지정예고(공시번복)
|
Korean | 5.0 KB | ||
| 2023-03-22 00:00 |
기타경영사항(자율공시)(감사보고서 제출 지연)
|
Korean | 5.8 KB | ||
| 2023-03-15 00:00 |
주주총회집중일개최사유신고
|
Korean | 4.6 KB | ||
| 2023-03-15 00:00 |
주주총회소집결의
|
Korean | 15.0 KB | ||
| 2023-03-15 00:00 |
주주총회소집공고
|
Korean | 221.5 KB | ||
| 2023-03-10 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 76.0 KB | ||
| 2023-03-06 00:00 |
[기재정정]투자판단관련주요경영사항(오피란제린 주사제 한국 임상3상 Topline 결과 발표)
|
Korean | 33.5 KB | ||
| 2023-02-28 00:00 |
증권발행결과(자율공시)(제3자배정 유상증자)
|
Korean | 5.6 KB | ||
| 2023-02-28 00:00 |
[기재정정]전환청구권행사(제19회차)
|
Korean | 12.0 KB | ||
| 2023-02-24 00:00 |
[기재정정]수시공시의무관련사항(공정공시)(코로나19 검체수송배지 등 공급계약(기본계약) 해지 결정)
|
Korean | 10.0 KB | ||
| 2023-02-22 00:00 |
전환청구권행사(제19회차)
|
Korean | 8.9 KB | ||
| 2023-02-07 00:00 |
투자판단관련주요경영사항((오피란제린 주사제 한국 임상3상 유효성 일차평가항목 결과 발표))
|
Korean | 12.1 KB | ||
| 2023-01-18 00:00 |
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 66.7 KB | ||
| 2023-01-09 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 22.5 KB |
Automate Your Workflow. Get a real-time feed of all VIVOZON PHARMACEUTICAL CO., LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for VIVOZON PHARMACEUTICAL CO., LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for VIVOZON PHARMACEUTICAL CO., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
